UMC Hospitals, Navi Mumbai, part of NSE-listed unihealth hospitals Limited, announced on July 29, 2026, the successful completion of Navi Mumbai's first Bilateral Robotic Direct Anterior Approach (DAA) Total Hip Replacement. The procedure marks a significant advancement in minimally invasive and technology-enabled hip replacement surgery in the region. The surgery was performed by Dr. Avinashdev Upadhyay, Consultant Orthopaedic and Robotic Joint Replacement Surgeon at UMC Hospitals, Navi Mumbai, who has undergone advanced fellowship training in Australia in Robotic Hip & Knee Replacement Surgery and Direct Anterior Hip Replacement.

Patient Background and Clinical Indication

The patient, a 67-year-old gentleman from Hubballi, Karnataka, travelled hundreds of kilometres to Navi Mumbai seeking specialised treatment after suffering from Stage IV Avascular Necrosis (AVN) of both hip joints for nearly three years. Avascular necrosis is a progressive condition in which reduced blood supply to the femoral head results in deterioration and eventual collapse of the hip joint. In advanced stages, patients can experience significant pain, stiffness, and progressive loss of mobility, with routine activities such as walking, climbing stairs, getting up from a chair, and sitting comfortably becoming increasingly difficult. The bilateral nature and advanced stage of the disease had substantially affected the patient's mobility and quality of life prior to the procedure.

Procedure Details: Combining Two Advanced Approaches

The procedure represents the convergence of two advanced approaches in modern hip replacement surgery. The key features of the surgical approach are outlined below:

The Direct Anterior Approach (DAA) accesses the hip joint through the front of the hip, working through natural intermuscular and inter-nervous tissue planes. Unlike traditional approaches that may involve cutting or detaching muscles, the DAA is designed to preserve surrounding musculature and soft tissues as much as possible. This may contribute to reduced tissue trauma, lower post-operative discomfort, early mobilisation, and faster functional recovery in appropriately selected patients.

The addition of Robotic-Assisted Technology provides a further layer of precision. Based on detailed pre-operative imaging and planning, the surgical team can assess the patient's individual anatomy and plan the positioning, alignment, and sizing of implants. During surgery, the robotic platform assists the surgeon with execution of this plan and provides real-time information to support accurate bone preparation and implant positioning. Importantly, the robotic system assists rather than replaces the surgeon—clinical judgement, surgical expertise, and intra-operative decision-making remain central to the procedure.

Same-Day Mobilisation: A Notable Early Outcome

One of the most notable aspects of the procedure was the patient's early mobilisation. Following surgery, the patient was able to stand and walk with assistance on the same day, under the supervision of the treating clinical and rehabilitation team. For a patient who had experienced significant limitations in mobility for several years due to bilateral advanced AVN, being able to stand and take assisted steps on the day of surgery represented a particularly encouraging early outcome. Recovery varies from patient to patient depending on age, overall health, bone quality, muscle strength, disease severity, and other clinical factors.

Building Advanced Orthopaedic Capabilities at UMC Hospitals

The successful completion of this procedure strengthens UMC Hospitals, Navi Mumbai's capabilities in advanced Robotic-Assisted Joint Replacement and Minimally Invasive Orthopaedic Surgery. The hospital's approach integrates specialist clinical talent, advanced technology, dedicated operating infrastructure, and post-operative rehabilitation protocols. The hospital's growing orthopaedic capabilities are expected to support patients from across Maharashtra and other parts of India, including those seeking specialised treatment through India's expanding medical value travel ecosystem.

Commenting on the milestone, Dr. Akshay Parmar, Managing Director, Unihealth Hospitals Limited, said: "This milestone reflects the clinical expertise and advanced capabilities we are steadily building across the UMC Hospitals network. The successful completion of a Bilateral Robotic Direct Anterior Hip Replacement at UMC Hospital, Navi Mumbai, demonstrates that highly advanced orthopaedic care can now be delivered with the precision, technology and clinical standards expected at leading centres globally. Healthcare is ultimately about outcomes and access. Our focus at UMC Hospitals is to combine clinical excellence with technology and accessibility, so that patients do not have to look only towards a handful of metropolitan centres – or outside the country – when they require advanced and specialised care."

Dr. Avinashdev Upadhyay added: "The combination of the Direct Anterior Approach and robotic-assisted technology allowed us to work through a minimally invasive, muscle-sparing surgical pathway while using technology to support detailed planning and accurate execution. Early mobilisation is an important component of modern joint replacement care. The fact that the patient was able to stand and walk with assistance on the same day was an encouraging early milestone in his recovery."

About Unihealth Hospitals Limited

Founded in Mumbai in 2010, Unihealth Hospitals Limited is an integrated healthcare platform focused on delivering affordable, accessible, and high-quality healthcare services across India and East Africa. The Company operates across multiple healthcare verticals, including hospital operations, healthcare consultancy, pharmaceutical and consumables exports, and medical value travel. The Company was listed on NSE Emerge in September 2023. Key financial highlights for FY26 are as follows:

Unihealth Hospitals Limited shareholders approved all 12 resolutions proposed at the company’s 17th Annual General Meeting (AGM), which was conducted via video conferencing on July 28, 2026. The unanimous backing across ordinary and special resolutions signals strong stakeholder confidence in the company’s governance structure, leadership continuity, and strategic operational plans involving related-party entities. The meeting commenced at 12:43 p.m. and concluded at 01:02 p.m., adhering to regulatory frameworks set by the Ministry of Corporate Affairs (MCA) and the Securities and Exchange Board of India (SEBI).

The voting process complied with Regulation 44(3) of the SEBI Listing Regulations and Section 108 of the Companies Act, 2013. Remote e-voting was available from July 25, 2026, at 9:00 a.m. to July 27, 2026, at 5:00 p.m., facilitated by National Securities Depository Limited (NSDL). Shareholders holding shares as of the cut-off date of July 21, 2026, were eligible to vote. A total of 1,229 shareholders were on record, with 5 promoter group members and 12 public shareholders attending the meeting through video conferencing.

Governance and Leadership Changes

The Board secured unanimous approval for key leadership transitions and compensation adjustments. Dr. Akshay M. Parmar, Chairman and Managing Director, was reappointed after retiring by rotation. Additionally, shareholders approved a revision in his remuneration via a special resolution. Mr. Parag Shah, Executive Director and Chief Financial Officer, also received shareholder approval for a revision in his remuneration.

Mr. Bachh Raj Nahar was appointed as an Independent Director through an ordinary resolution. These appointments reinforce the company’s commitment to maintaining a robust and experienced board structure.

Capital Structure and Strategic Transactions

Shareholders passed special resolutions to increase the authorized share capital and to issue equity shares on a preferential basis for consideration other than cash. These measures provide the company with greater flexibility to raise capital and execute strategic investments without diluting existing shareholders’ rights through open market offerings.

Furthermore, the AGM approved multiple material related-party transactions essential for the company’s integrated healthcare operations. These include transactions with UMC Hospitals Private Limited, Victoria Hospital Limited in Uganda, and Unihealth Tanzania Limited. Additional approvals covered transactions between wholly owned subsidiary Unihealth Holdings Limited (UHL) and Unihealth Tanzania Limited, as well as between Unihealth Pharmaceuticals Private Limited (UPPL) and associate company Unihealth (U) Limited.

Voting Results Summary

All resolutions received 100% support from the valid votes cast. Shalini Bhat of Parikh & Associates served as the scrutinizer for the e-voting process. The detailed voting outcomes are presented below.

What the Numbers Show

The voting data reveals a distinct bifurcation in participation levels between governance-related resolutions and related-party transaction approvals. While over 11.4 million votes were cast on standard agenda items such as financial statement adoption and board appointments, only approximately 445,540 votes were recorded for the five material related-party transaction resolutions. This discrepancy likely reflects abstention or conflict-of-interest disclosures by major stakeholders involved in these specific transactions, while still resulting in unanimous approval from the eligible voting pool for each item.